Refobacin Revision-3 Bone Cement Post-Market Study

NCT06699160 · clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The study was discontinued upon availability of relevant data through bespoke reporting, which fulfilled the study's primary objectives

Conditions

Interventions

Sponsor

Zimmer Biomet